Kinetic characteristics of the erythrocyte sodium-lithium countertransporter in subjects with coronary artery disease

American Journal of Hypertension

Volumn 9, Issue 2, 1996, Pages 184-187

  Hardman, Timothy C ^a   Barlow, Richard ^a   Dubrey, Simon W ^b   Croft, Paula ^a   Lant, Ariel F ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

coronary artery disease; erythrocytes; sodium lithium countertransport

Indexed keywords

LITHIUM; SODIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ERYTHROCYTE; HUMAN; HYPERTENSION; ION TRANSPORT; LITHIUM CELL LEVEL; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SODIUM CELL LEVEL;

EID: 0029922294     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(95)00347-9     Document Type: Article

References (14)

1. Rutherford PA, Thomas TH, Wilkinson R: Increased erythrocyte sodium-lithium countertransport activity in essential hypertension is due to an increased affinity for extracellular sodium. Clin Sci 1990;79:365-369.
2. Hardman TC, Croft P, Barlow R, et al: Ethnic origin and hypertension-associated alterations in sodium-lithium countertransport (SLC) kinetics. J Hum Hypertens 1995;9:687-689.
3. Laurenzi M, Trevisan M: Sodium-lithium countertransport and blood pressure: the Gubbio Population Study. Hypertension 1989;13:408-415.
4. Rutherford PA, Thomas TH, Wilkinson R: Erythrocyte sodium-lithium countertransport: clinically useful, pathophysiologically instructive or just phenomenology? Clin Sci 1992;82:341-352.
5. Bunker CH, Mallinger AG, Adams LL, et al: Red blood cell sodium-lithium countertransport and cardiovascular risk factors in black and white college students. J Hypertens 1987;5:7-15.
6. Hardman TC, Dubrey SW, Soni, S, et al: Relationship of sodium-lithium countertransport activity to markers of cardiovascular risk in normotensive subjects. J Hum Hypertens 1995;9:589-596.
7. Hardman TC, Dubrey SW, Hafiz M, et al: Erythrocyte sodium-lithium countertransport and blood pressure in identical twin pairs discordant for insulin-dependent diabetes. Br Med J 1992;305:215-219.
8. Judkins MP: Selective coronary arteriography. I. A percutaneous transfemoral technic. Radiology 1967;89:815-824.
9. Krzesinski JM, Saint-Remy A, Du F, et al: Red blood cell Na-Li countertransport, hypertensive heredity, and cardiovascular risk in young adults. Am J Hypertens 1993;6:314-316.
10. Hardman TC, Sandhu S, Irving F, et al: Characterization of the erythrocyte sodium-lithium countertransporter (SLC) by traditional and kinetic methodologies (abst). Clin Sci 1993;84:26P.
11. + countertransport and electrolyte composition in erythrocytes of patients with essential hypertension before and after antihypertensive treatment. Klin Wochenschr 1986;64:1101-1105.
12. De la Sierra A, Insa R, Compte M, et al: Effect of long-term antihypertensive therapy with angiotensin converting enzyme inhibitors on red cell sodium transport. Am J Hypertens 1995;8:622-625.
13. + exchange. Hypertension 1987;9:7-12.
14. Resnick LM: Cellular ions in hypertension, insulin resistance, obesity and diabetes: a unifying theme. J Am Soc Nephrol 1992;3:S78-S85.